GE's non-invasive SMS-EIT prototype system provides higher signal-to-noise ratio and greater sensitivity to continuously image pulmonary perfusion and ventilation.

Low-cost manufacturing platform for disposable, hospital-grade multi-parameter clinical monitoring devices.

Hydration status monitoring based on wearable sweat-based sensing

Translating the promise of AR to the reality of industry

Adaptive AI in the virtual flesh... deploying virtual agents to learn how to convince you to take positive actions

In 1990 Dr. Tu joined Sony Research in Tokyo Japan, where he developed a number of computer vision algorithms for man-machine interfaces. While at Oxford University, his research was devoted to the development of computer vision methods for the autumatic analysis of seismic imagery.

Imaging is an essential non-invasive tool for building disease understanding and characterization. Contrast agents or targeted imaging (molecular imaging) allow specific features to be delineated, such as vascularization, abnormal metabolism, or disease-specific biomarkers. GE Research has an active program developing molecular imaging agents that benefits from our strong capabilities in diagnostic imaging hardware and histopathogical technology for characterization of biomarkers in diseased tissue.

Cell DIVE™ is a powerful and innovative commercial technology platform that enables a researcher to analyze single 5 um tissue section with up to 60 biomarker stains.

GE Research developed a novel method for automated tissue multiplexing.

Combining genetically variable peptides and DNA profiling to enable single contributor identification via proteomics for forensic applications.